Loading…
QED Bioscience, now part of Leinco Technologies, provides antibodies, recombinant proteins, and contract services for research and diagnostic applications. The company specializes in reagents for infectious disease, cancer research, neuroscience, and therapeutic drug monitoring.
AI named QED Bioscience in December 2025.